US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Oncology Therapeutics, Inc

9.14

+0.06000.66%

Post-market: 9.250.1100+1.20%19:30 EDT

Volume:338.52K

Turnover:3.09M

Market Cap:731.10M

PE:-1.56

High:9.36

Open:9.10

Low:8.80

Close:9.08

52wk High:14.87

52wk Low:7.00

Shares:79.99M

Float Shares:35.75M

Volume Ratio:1.14

T/O Rate:0.95%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8439

EPS(LYR):-4.3039

ROE:-81.92%

ROA:-47.10%

PB:2.26

PE(LYR):-2.12

Loading ...

Overview Company News Filings

BridgeBio Oncology Therapeutics (BBOT) Receives a New Rating from Wedbush

Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28

BridgeBio Oncology Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate

Benzinga Earnings

BridgeBio Oncology Net Loss Widens 98,94% to USD 56,5 Juta in Q2 FY26

Bbot Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

THOMSON REUTERS

Press Release: BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

BridgeBio Oncology Therapeutics Inc Expected to Post a Loss of 57 Cents a Share - Earnings Preview

Bridgebio Oncology Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $27

THOMSON REUTERS

Analyst Initiates Buy on BridgeBio Oncology, Sees Significant Upside With $27 Price Target Amid Promising KRAS and PI3Kα Precision Oncology Pipeline

BridgeBio Oncology Therapeutics shareholders elect Lebowitz, McCormick to board

Morgan Stanley Sticks to Their Buy Rating for BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology’s New ERP Rollout Poses Significant Operational and Reporting Risks

Piper Sandler Sticks to Their Buy Rating for BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Bbot Reports First Quarter 2026 Financial Results And Update On Corporate Progress

BridgeBio Oncology Q1 EPS $(526.11) Down From (54.230) YoY,

Benzinga Earnings

BridgeBio Oncology net loss widens to $42.11 million in Q1 FY26

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBOT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":9.14,"timestamp":1787601600000,"preClose":9.08,"halted":0,"volume":338518,"hourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.14,"latestTime":"19:30 EDT","volume":7478,"amount":68439.12,"timestamp":1787614207210,"change":0.11,"changeRate":0.012035,"amplitude":0.012035},"delay":0,"changeRate":0.006607929515418557,"floatShares":35752400,"shares":79988687,"eps":-5.843879,"marketStatus":"Closed","change":0.06,"latestTime":"08-24 16:00:00 EDT","open":9.1,"high":9.3575,"low":8.8,"amount":3089191.70893,"amplitude":0.061399,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.843879,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":9.08,"preHourTrading":{"tag":"盘前","latestPrice":9.14,"preClose":9.08,"latestTime":"09:02 EDT","volume":12,"amount":109.80000000000001,"timestamp":1787576550596,"change":0.06,"changeRate":0.006608,"amplitude":0.002203},"postHourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.14,"latestTime":"19:30 EDT","volume":7478,"amount":68439.12,"timestamp":1787614207210,"change":0.11,"changeRate":0.012035,"amplitude":0.012035},"volumeRatio":1.139074},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":35752400,"roa":"-47.10%","roe":"-81.92%","lyrEps":-4.3039,"volumeRatio":1.139074,"shares":79988687,"dividePrice":0,"high":9.3575,"amplitude":0.061399,"preClose":9.08,"low":8.8,"week52Low":7,"pbRate":"2.26","week52High":14.87,"institutionHeld":0,"latestPrice":9.14,"eps":-5.843879,"divideRate":0,"volume":338518,"delay":0,"ttmEps":-5.843879,"open":9.1,"prevYearClose":12.52,"prevWeekClose":9.08,"prevMonthClose":8.09,"prevQuarterClose":7.62,"fiveDayClose":9.04,"twentyDayClose":8.75,"sixtyDayClose":8.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"BBOT","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-05-12","symbol":"BBOT","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.53},{"market":"US","date":"2026-03-05","symbol":"BBOT","fiscalQuarterEnding":"2025/12","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-12","symbol":"BBOT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.6364,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":11,"updateTime":1783742400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2026-08-21","current":-1.56403,"percent":0.948413,"low":-11.944957,"twenty":-9.757518,"median":-7.182237,"eighty":-4.533138,"high":-3.70137,"avg":-7.183327,"sd":2.49794,"marketCap":727982344},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-29","current":-9.336629,"twenty":-9.787158,"median":-9.514469,"eighty":-9.277349,"marketCap":816955023},{"date":"2025-09-05","current":-9.959071,"twenty":-9.864223,"median":-9.514469,"eighty":-9.247708,"marketCap":871418691},{"date":"2025-09-12","current":-10.047991,"twenty":-10.065775,"median":-9.65773,"eighty":-9.388005,"marketCap":879199215},{"date":"2025-09-19","current":-10.690193,"twenty":-10.20212,"median":-9.78123,"eighty":-9.467045,"marketCap":935391888},{"date":"2025-09-26","current":-11.678196,"twenty":-11.017222,"median":-9.944251,"eighty":-9.487793,"marketCap":1021842155},{"date":"2025-10-03","current":-11.259509,"twenty":-11.190123,"median":-10.077631,"eighty":-9.526325,"marketCap":985207072},{"date":"2025-10-10","current":-11.196152,"twenty":-11.224546,"median":-10.323455,"eighty":-9.563869,"marketCap":979663302},{"date":"2025-10-17","current":-10.3182,"twenty":-11.192532,"median":-10.372506,"eighty":-9.601414,"marketCap":902842494},{"date":"2025-10-24","current":-9.838494,"twenty":-11.156298,"median":-10.223893,"eighty":-9.601414,"marketCap":860868237},{"date":"2025-10-31","current":-10.861263,"twenty":-11.08659,"median":-10.23674,"eighty":-9.656742,"marketCap":950360520},{"date":"2025-11-07","current":-11.087539,"twenty":-11.118284,"median":-10.345353,"eighty":-9.745662,"marketCap":970159697},{"date":"2025-11-14","current":-11.205203,"twenty":-11.201583,"median":-10.472068,"eighty":-9.804136,"marketCap":980455269},{"date":"2025-11-21","current":-8.47671,"twenty":-11.192532,"median":-10.345353,"eighty":-9.572151,"marketCap":974262207},{"date":"2025-11-28","current":-8.567184,"twenty":-11.17443,"median":-10.251046,"eighty":-9.478901,"marketCap":984660736},{"date":"2025-12-05","current":-8.0313,"twenty":-11.121014,"median":-10.182434,"eighty":-9.298176,"marketCap":923069447},{"date":"2025-12-12","current":-8.936039,"twenty":-11.105583,"median":-10.084778,"eighty":-9.061365,"marketCap":1027054741},{"date":"2025-12-19","current":-8.389716,"twenty":-11.080298,"median":-9.97426,"eighty":-8.826299,"marketCap":964263621},{"date":"2025-12-26","current":-8.490629,"twenty":-11.051335,"median":-9.938056,"eighty":-8.720294,"marketCap":975861981},{"date":"2026-01-02","current":-8.713334,"twenty":-11.00789,"median":-9.919954,"eighty":-8.650698,"marketCap":1001458361},{"date":"2026-01-09","current":-9.256178,"twenty":-10.960825,"median":-9.809862,"eighty":-8.597806,"marketCap":1063849537},{"date":"2026-01-16","current":-8.003462,"twenty":-10.901088,"median":-9.61327,"eighty":-8.567184,"marketCap":919869900},{"date":"2026-01-23","current":-7.829474,"twenty":-10.885701,"median":-9.557912,"eighty":-8.530995,"marketCap":899872728},{"date":"2026-01-30","current":-8.699415,"twenty":-10.880305,"median":-9.521034,"eighty":-8.553265,"marketCap":999858587},{"date":"2026-02-06","current":-7.063925,"twenty":-10.867923,"median":-9.470009,"eighty":-8.485061,"marketCap":811885173},{"date":"2026-02-13","current":-7.947786,"twenty":-10.83411,"median":-9.398729,"eighty":-8.38554,"marketCap":913470805},{"date":"2026-02-20","current":-7.043047,"twenty":-10.812388,"median":-9.272371,"eighty":-8.35979,"marketCap":809485512},{"date":"2026-02-27","current":-7.13352,"twenty":-10.763512,"median":-9.179623,"eighty":-8.144045,"marketCap":819884041},{"date":"2026-03-06","current":-6.882977,"twenty":-10.695084,"median":-9.036987,"eighty":-8.006246,"marketCap":791088114},{"date":"2026-03-13","current":-5.451193,"twenty":-10.678337,"median":-8.936039,"eighty":-7.945698,"marketCap":730699673},{"date":"2026-03-20","current":-5.403428,"twenty":-10.588779,"median":-8.821207,"eighty":-7.854528,"marketCap":724297048},{"date":"2026-03-27","current":-5.510899,"twenty":-10.477499,"median":-8.762051,"eighty":-7.489849,"marketCap":738702956},{"date":"2026-04-02","current":-5.391486,"twenty":-10.453966,"median":-8.733947,"eighty":-7.421645,"marketCap":722696391},{"date":"2026-04-10","current":-5.287,"twenty":-10.379747,"median":-8.713334,"eighty":-7.088979,"marketCap":708690647},{"date":"2026-04-17","current":-5.504928,"twenty":-10.361645,"median":-8.657658,"eighty":-7.020776,"marketCap":737902628},{"date":"2026-04-24","current":-5.355662,"twenty":-10.30763,"median":-8.605462,"eighty":-6.799463,"marketCap":717894422},{"date":"2026-05-01","current":-5.021307,"twenty":-10.25963,"median":-8.567184,"eighty":-5.98855,"marketCap":673076041},{"date":"2026-05-08","current":-4.692922,"twenty":-10.225879,"median":-8.553265,"eighty":-5.587323,"marketCap":629057988},{"date":"2026-05-15","current":-4.419866,"twenty":-10.182434,"median":-8.490629,"eighty":-5.506122,"marketCap":681079323},{"date":"2026-05-22","current":-4.73149,"twenty":-10.167401,"median":-8.47671,"eighty":-5.429101,"marketCap":729099017},{"date":"2026-05-29","current":-4.595521,"twenty":-10.107271,"median":-8.403635,"eighty":-5.355662,"marketCap":708146799},{"date":"2026-06-05","current":-4.278409,"twenty":-10.091924,"median":-8.379277,"eighty":-5.319839,"marketCap":659281465},{"date":"2026-06-12","current":-3.878121,"twenty":-10.077631,"median":-8.309681,"eighty":-5.287,"marketCap":597598995},{"date":"2026-06-18","current":-3.992489,"twenty":-10.053919,"median":-8.201809,"eighty":-5.246997,"marketCap":615222558},{"date":"2026-06-26","current":-3.997687,"twenty":-9.989006,"median":-8.066098,"eighty":-5.177737,"marketCap":616023629},{"date":"2026-07-02","current":-4.054871,"twenty":-9.965147,"median":-8.010422,"eighty":-5.018919,"marketCap":624835411},{"date":"2026-07-10","current":-4.725485,"twenty":-9.946462,"median":-7.965184,"eighty":-4.959212,"marketCap":728173575},{"date":"2026-07-17","current":-4.319998,"twenty":-9.932881,"median":-7.944306,"eighty":-4.729088,"marketCap":665690034},{"date":"2026-07-24","current":-4.533138,"twenty":-9.923745,"median":-7.895589,"eighty":-4.678698,"marketCap":698533946},{"date":"2026-07-31","current":-4.41877,"twenty":-9.900032,"median":-7.829474,"eighty":-4.589283,"marketCap":680910384},{"date":"2026-08-07","current":-4.56433,"twenty":-9.857488,"median":-7.544133,"eighty":-4.574377,"marketCap":703340373},{"date":"2026-08-14","current":-4.060031,"twenty":-9.815588,"median":-7.439739,"eighty":-4.568002,"marketCap":739388569},{"date":"2026-08-21","current":-3.997399,"twenty":-9.757518,"median":-7.182237,"eighty":-4.533138,"marketCap":727982344}],"updateTime":1787617312855},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBOT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658035829","title":"BridgeBio Oncology Therapeutics (BBOT) Receives a New Rating from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2658035829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658035829?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:55","pubTimestamp":1786542924,"startTime":"0","endTime":"0","summary":"Wedbush analyst initiated coverage with a Buy rating on BridgeBio Oncology Therapeutics today and set a price target of $25.00. In a report release...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-new-rating-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-new-rating-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997785","title":"Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997785?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537240,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 908 Devices (MASS), Pediatrix Medical Group (MD) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","MASS","XLV","BK4588","BK4585","BK4581","MD","BK4139","LABU","XBI","LU0128526141.USD","BBOT","LU0029874061.USD","BK4157","BK4196","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658145945","title":"BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28","url":"https://stock-news.laohu8.com/highlight/detail?id=2658145945","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658145945?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:54","pubTimestamp":1786481656,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics beri opsi saham 65.350 lembar kepada dua karyawan baru dengan harga pelaksanaan USD 9,28Bridgebio Oncology Therapeutics memberikan opsi saham non-kualifikasi untuk tota","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL5l5hY9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4588","BK4139","BK4505","BBOT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945316","title":"BridgeBio Oncology Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945316?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:40","pubTimestamp":1786480800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA9LS1YX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658147945","title":"BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658147945","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658147945?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:40","pubTimestamp":1786480800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Aug.  11, 2026  (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malign","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3343195/0/en/bridgebio-oncology-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BBOT","BK4139","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945387","title":"BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945387","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945387?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:39","pubTimestamp":1786480750,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(705.20) per share which missed the analyst consensus estimate of $(0.57) by 123619.3 percent. This is a 24.49 percent decrease over losses of $(566.46) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61128346/bridgebio-oncology-q2-eps-705-20-misses-0-57-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943580","title":"BridgeBio Oncology Net Loss Widens 98,94% to USD 56,5 Juta in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943580","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943580?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:15","pubTimestamp":1786479339,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology net loss widens 98,94% to USD 56,5 juta in Q2 FY26Bridgebio Oncology Therapeutics membukukan rugi bersih kuartal II 2026 melebar menjadi USD 56,5 juta dari USD 28,4 juta setahun seb","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLyc3Gz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658489199","title":"Bbot Reports Second Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658489199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658489199?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA65NFJY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948041","title":"Press Release: BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948041","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948041?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":"-- Continued to advance monotherapy and combination cohorts for all clinical. -- Initiated dosing of BBO-11818 in combination with cetuximab and after the. end of the quarter, initiated dosing of BBO-11818 in combination with. -- Presented preclinical data at AACR highlighting the potency and activity. of BBO-11818 in KRAS mutant tumor models and the efficacy of BBO-10203 in. combination with tucatinib and trastuzumab in HER2amp models. -- Initiated BBO-8520 plus BBO-10203 combination in patients with G12C. NSCLC.BBO-11818: An orally bioavailable small molecule pan-KRAS inhibitor that targets mutant KRAS in both the ON and OFF states.-- Continued to enroll BBO-11818 monotherapy across multiple dose levels.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","LU0266512127.USD","BK4213","BK4139","LU0456854461.SGD","BBOT","PRGS","CRC","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654102850","title":"BridgeBio Oncology Therapeutics Inc Expected to Post a Loss of 57 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2654102850","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654102850?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:16","pubTimestamp":1785183366,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics Inc <BBOT.OQ> expected to post a loss of57cents a share - Earnings PreviewBridgeBio Oncology Therapeutics IncBBOT.OQBBOT.Ois expected to  report resultson July 29 (esti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL8N43T1XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BBIO","BK4139","BK4505","BBOT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649199384","title":"Bridgebio Oncology Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $27","url":"https://stock-news.laohu8.com/highlight/detail?id=2649199384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649199384?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:37","pubTimestamp":1783510640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649184962","title":"Analyst Initiates Buy on BridgeBio Oncology, Sees Significant Upside With $27 Price Target Amid Promising KRAS and PI3Kα Precision Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2649184962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649184962?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:45","pubTimestamp":1783503930,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics (BBOT) has received a new Buy rating, initiated by J.P. Morgan analyst, . Analyst has given his Buy rating due to a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-bridgebio-oncology-sees-significant-upside-with-27-price-target-amid-promising-kras-and-pi3k-precision-oncology-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-bridgebio-oncology-sees-significant-upside-with-27-price-target-amid-promising-kras-and-pi3k-precision-oncology-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1732800096.USD","LU0098860793.USD","LU2089284900.SGD","LU2111349929.HKD","LU1074936037.SGD","LU1732799900.SGD","LU1720051108.HKD","LU2264538146.SGD","IE00BKVL7J92.USD","LU0390134368.USD","LU0225283273.USD","LU2357305700.SGD","LU0314104364.USD","KBWB","BK4139","LU0158827781.USD","LU0971096721.USD","LU2023251221.USD","LU1989772840.SGD","BBOT","BK4504","LU2089283258.USD","LU0106261372.USD","BK4585","BK4588","LU2347655156.SGD","LU0528227936.USD","LU0912757837.SGD","LU1363072403.SGD","LU0267386448.USD","LU1548497426.USD","LU0053666078.USD","LU0320765646.SGD","LU1668664300.SGD","LU1791710582.SGD","LU2271345857.HKD","LU0158827948.USD","LU0210528500.USD","LU1244550494.USD","LU2487616109.SGD","LU0234570918.USD","LU1244550221.USD","LU1988902786.USD","BK4127","LU1244550577.SGD","LU1162221912.USD","LU2028103732.USD","IE00BZ1G4Q59.USD","IAI","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645077100","title":"BridgeBio Oncology Therapeutics shareholders elect Lebowitz, McCormick to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2645077100","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645077100?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:06","pubTimestamp":1782158791,"startTime":"0","endTime":"0","summary":"Bridgebio Oncology Therapeutics held its annual shareholder meeting on June 16, 2026.Shareholders backed the selection of two directors to serve through the 2029 annual meeting.Shareholders ratified Deloitte & Touche as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridgebio Oncology Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL7nB2Sr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BBOT","BK4505","BK4588","BBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087051","title":"Morgan Stanley Sticks to Their Buy Rating for BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087051?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:15","pubTimestamp":1778850928,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Buy rating on BridgeBio Oncology Therapeutics, with a price target of $8.5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635608917","title":"BridgeBio Oncology’s New ERP Rollout Poses Significant Operational and Reporting Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635608917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635608917?lang=en_us&edition=fundamental","pubTime":"2026-05-14 14:01","pubTimestamp":1778738488,"startTime":"0","endTime":"0","summary":"Bridgebio Oncology Therapeutics, Inc. (BBOT) has disclosed a new risk, in the Technology category. Bridgebio Oncology Therapeutics, Inc. faces exec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bridgebio-oncologys-new-erp-rollout-poses-significant-operational-and-reporting-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bridgebio-oncologys-new-erp-rollout-poses-significant-operational-and-reporting-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635815547","title":"Piper Sandler Sticks to Their Buy Rating for BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635815547","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635815547?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:37","pubTimestamp":1778672251,"startTime":"0","endTime":"0","summary":"In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on BridgeBio Oncology Therapeutics, with a price target of $21.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635226626","title":"BridgeBio Oncology Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635226626","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635226626?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:30","pubTimestamp":1778625003,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryBridgeBio Oncology Therapeutics Inc BBOT.OQ reported a quarterly adjusted loss of 53 cents per shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P3BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BBOT","BK4585","BK4139","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635257072","title":"Bbot Reports First Quarter 2026 Financial Results And Update On Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635257072","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635257072?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:08","pubTimestamp":1778623728,"startTime":"0","endTime":"0","summary":"May 12 (Reuters) - BridgeBio Oncology Therapeutics Inc ::*BBOT REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND UPDATE ON CORPORATE PROGRESS*BRIDGEBIO ONCOLOGY THERAPEUTICS INC: CASH RUNWAY EXPECTED T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nRSD8qKHxJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635225197","title":"BridgeBio Oncology Q1 EPS $(526.11) Down From (54.230) YoY,","url":"https://stock-news.laohu8.com/highlight/detail?id=2635225197","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635225197?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:54","pubTimestamp":1778622867,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(526.11).This is a 870.15 percent decrease over losses of $(54.23) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52510501/bridgebio-oncology-q1-eps-526-11-down-from-54-230-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQY","QLD","QQQA","ONEQ","BK4139","NQmain","NVIW.SI","QQQ","FTEC","QID","JEPQ","NDX","BBOT","QQQJ","MNQmain","QQQE","SQQQ",".IXIC","QDTE","TQQQ","IYW","TQQY","PSQ","GPIQ","TECS","QYLG","QQQM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223806","title":"BridgeBio Oncology net loss widens to $42.11 million in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223806","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223806?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:03","pubTimestamp":1778619833,"startTime":"0","endTime":"0","summary":"Bridgebio Oncology Therapeutics posted a net loss of USD 42.1 million, widening from USD 22.1 million a year earlier.R&D expense more than doubled to USD 39.8 million, while G&A expense climbed to USD 6.4 million as standalone operations ramped following de-SPAC.Cash, cash equivalents, and marketable securities totaled USD 388.9 million, with runway expected to fund operations into 2028.Pipeline update flagged a 65% objective response rate for BBO-8520 monotherapy in KRASG12C NSCLC, a partial response with 56% tumor reduction for BBO-11818 in pancreatic cancer, and full target engagement without hyperglycemia for BBO-10203.Updated clinical data across all three programs are expected in second half of 2026, with internal combination studies advancing during 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL8mJkK2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4112","SG9999014039.USD","BK4585","BK4139","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014005.SGD","NDAQ","IE00BN0W2V16.EUR","BBOT","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}]}}